Advancing innovation starts with participation.
Ardelyx's clinical trials website helps patients and caregivers explore ongoing studies, eligibility, and what participation may involve.
Learn more about our efforts: bit.ly/4kaP9PV
IBS-C affects millions, yet many patients are still told it’s “just” a condition.
Ardelyx is focused on advancing care for people living with IBS-C, with an emphasis on improving patient outcomes and addressing treatment gaps.
Learn more: bit.ly/3YI83Gs
At Ardelyx, we’re advancing therapies for conditions like IBS-C and chronic kidney disease, while continuing to invest in future treatments that could redefine care.
Learn more about what we’re building: bit.ly/49D9r30
What does #ArdelyxProud mean to our team?
For May Liu-Dacey, it comes down to the people — being part of a team that shows up for each other, leans into challenges, and stays grounded in a shared commitment to delivering for patients.
Learn more: bit.ly/4dbV9oj
Save the date! Today we announced that management will present at the @Jefferies Global Healthcare Conference on Wednesday June 3 at 9:55 am ET in New York. Learn more: bit.ly/4wFCpIt#JefferiesHealthcare$ARDX
Be part of a team that values dedication, inclusivity, and fearless innovation — join Team Ardelyx in making a real impact for patients in need. Learn more: bit.ly/4dbV9oj#ArdelyxProud
Wrapping up an inspiring week at @nkf's Spring Clinical Meetings – thankful to connect with passionate members of the #kidney community and engage in so many meaningful conversations! #NKFClinicals
This #NationalNursesWeek, we recognize the nurses who are at the center of patient care every day.
Your expertise, compassion, and advocacy make a lasting difference for patients, their families, and the broader healthcare community. We're grateful for all that you do!
Today we announced a poster presentation of a post-hoc analysis of the OPTIMIZE and NORMALIZE studies at the @nkf's Spring Clinical Meetings, currently underway in New Orleans. Learn more: bit.ly/4whEzxL#NKFClinicals
Reflecting on an incredible @DDWMeeting spent with the #GI community. We appreciate everyone who stopped by to connect with Team Ardelyx. Here's to even more innovation and collaboration ahead! #DDW2026
Last month, landmarks – from Niagara Falls to the Prudential Center, San Francisco State House, and the Hoan Bridge – glowed purple in honor of #WorldIBSDay2026. At Ardelyx, we’re proud to join the #IBS-C community in shining a light on awareness and understanding. #ArdelyxProud
Today we reported financial results for the first quarter ended March 31, 2026, and provided a business update. Read the full press release here: bit.ly/4t7I4UQ$ARDX
Connect with Team Ardelyx at the @nkf's Spring Clinical Meetings in New Orleans! Today, we announced an abstract accepted for poster presentation and shared details for our sponsored peer exchange. For more details: bit.ly/4cQ1448#NKFClinicals
Tina didn’t always feel comfortable opening up about her #IBS‑C. Over years of managing her condition and building a strong support network, she’s become a proud advocate for herself and others. #IBSAwarenessMonth
Tina’s journey: bit.ly/3YWynwX
We're pleased to share that we'll be attending at the upcoming @DDWMeeting in Chicago! Make sure to stop by our booth, engage in our poster session, and attend our product theater. For more details: bit.ly/3OZWjwN#DDW2026
We're pleased to announce the appointment of of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer.
Excited to welcome her to Team Ardelyx! Learn more: bit.ly/3QniCge
Save the date! We will present our first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026, at 4:30 pm ET via live webcast and conference call. Learn more: bit.ly/486UvZh$ARDX
April is #IBSAwarenessMonth! We’re proud to spotlight the advocacy partners who work every day to support the #IBS‑C community. Thank you for your dedication and the meaningful impact you make all year long.
For many living with #IBS-C, getting to a diagnosis can be a long and emotional journey. Nancy shares how finally being understood and finding the right support made all the difference.
Learn more about Nancy's journey: bit.ly/44vOAv4
Ardelyx is honored to be named #12 on the @FinancialTimes's Fastest Growing Companies of 2026 list!
This recognition reflects our commitment to advancing innovative medicines for patients and is a testament to the dedication of Team Ardelyx.
ft.com/content/3d3b5406-b7e6…